Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study - Caffo, O; De Giorgi, U; Fratino, L (Eur Urol, 2015)
et al.